Psychiatr. pro Praxi, 2001; 2: 84

Antidepresiva a QT interval

prof. MUDr. Jaromír ©vestka DrSc
Psychiatrická klinika LF MU a FN Brno

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©vestka J. Antidepresiva a QT interval. Psychiatr. praxi. 2001;2(2):84.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baker B, Dorian P, Sandor P et al.: Electrocardiographic effects of fluoxetine and doxepine in patients with major depressive disorder. J. Clin. Psychopharmacol. 1997; 17: 15-21. Go to original source... Go to PubMed...
    2. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am. J. Med. 2000; 108: 2-8. Go to original source... Go to PubMed...
    3. Fisch C. Effect of fluoxetine on electrocardiogram. J. Clin. Psychiatry 1985; 46: 42-44.
    4. Glassman H, Cardiovascular effects of antidepressant drugs: Updated. J. Clin. Psychiatry 1998; 59 (Suppl.15): 13-18. Go to original source... Go to PubMed...
    5. Hergovich N, Aigner M, Eichler HG et al. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin. Pharmacol. Ther. 2000; 68: 435-442. Go to original source... Go to PubMed...
    6. Lherm T. Lottin F, Larbi D et al. Torsade de pointes after poisoning with fluoxetine alone. Presse Med 2000; 29: 306-307.
    7. Nelson JC, Kennedy JS, Pollock BG et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am. J. Psychiatry 1999; 156: 1024-1028. Go to original source... Go to PubMed...
    8. Paclt I, Slaviček J, Florian J. Deprese, kardiovaskulární choroby a neľádoucí účinky antidepresiv. Psychiatrie pro praxi 2000; 3: 86-95.
    9. Reilly G, Ayis S, Ferrier N et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000; 355: 1048-1052. Go to original source... Go to PubMed...
    10. Reznik I, Rosen Y, Rosen B. An acute ischemic event associated with the use of venlafaxine. J. Psychopharmacology 1999; 13: 193-195. Go to original source... Go to PubMed...
    11. Roose SP, Glassman AH, Attia E et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am. J. Psychiatry 1998; 155: 660-665. Go to original source... Go to PubMed...
    12. Shapiro PA, Lespérance F, Frasure-Smith N et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT trial). Am. Heart J. 1999; 137: 1100-1106. Go to original source... Go to PubMed...
    13. Strik J. Honig A, Lousberg R et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosomatic Medicine 2000; 62: 783-789. Go to original source... Go to PubMed...
    14. Strik J. Honig A, Lousberg R et al. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients. Int. Clin. Psychopharmacology 1998; 13: 263-267. Go to original source... Go to PubMed...
    15. Varriale P. Fluoxetine (Prozac) as a cuase of QT prolongation. Arch. Intern. Med. 2001; 161: 612. Go to original source... Go to PubMed...
    16. www.Torsades.org
    17. www.georgetown.edu/departments/pharmacology/torsades.html

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.